Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor metadata update with no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the site-wide notice about potential delays due to a lapse in government funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedNo additions or deletions were detected on the page; the visible content appears unchanged.SummaryDifference0.4%

- Check62 days agoChange Detected- Updated operating status notice and new version tag (v3.2.0) replacing v3.1.0. The page now informs users about potential delays due to funding and directs to official sources for status; previous version marker v3.1.0 was removed.SummaryDifference3%

- Check69 days agoChange DetectedAdded revision: v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag v3.0.2.SummaryDifference0.4%

- Check84 days agoChange DetectedUpdated to v3.0.2 (Sept 2025) with new 2025 dates and an estimated last-update label. Added ACT17131 plain-language results link from Sanofi/Principia Biopharma, while older entries, revision v3.0.1, and 'Back to Top' were removed.SummaryDifference1%

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.